The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Application of PET RANO 1.0 criteria and associations with outcome in IDH-mutant gliomas: A retrospective cohort study.
 
Maximilian Mair
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Pierre Fabre
 
Thedora Aras-Brendler
No Relationships to Disclose
 
Jonas Reis
No Relationships to Disclose
 
Isabelle von Polenz
No Relationships to Disclose
 
Lilian Wiegand
No Relationships to Disclose
 
Roman Stuerzl
No Relationships to Disclose
 
Enio Barci
No Relationships to Disclose
 
Katharina Mueller
No Relationships to Disclose
 
Jonathan Weller
No Relationships to Disclose
 
Sophie Katzendobler
No Relationships to Disclose
 
Matthias Preusser
Honoraria - Abbvie; Adastra Pharmaceuticals; Advanced Accelerator Applications; AstraZeneca; Bayer; BMJ Journals; Boehringer Ingelheim; Bristol-Myers Squibb; CMC Contrast; Crinetics Pharmaceuticals; Daiichi Sankyo; Gan & Lee; Gerson Lehrman Group; GlaxoSmithKline; ITM Oncologics; Janssen; Lilly; Medac; Medahead; MedMedia; Medscape; Merck Sharp & Dohme; Miltenyi Biotec; Mundipharma; Nerviano Medical Sciences; Novartis; OncLive; Roche; Sanofi; SERVIER; Telix Pharmaceuticals; Tocagen
Consulting or Advisory Role - Abbvie; Adastra Pharmaceuticals; Advanced Accelerator Applications; AstraZeneca; Bayer; BMJ Journals; Boehringer Ingelheim; Bristol-Myers Squibb; CMC Contrast; Crinetics Pharmaceuticals; Daiichi Sankyo; Gan & Lee; Gerson Lehrman Group; GlaxoSmithKline; ITM Oncologics; Janssen; Lilly; Medac; Medahead; MedMedia; Medscape; Merck Sharp & Dohme; Miltenyi Biotec; Mundipharma; Nerviano Medical Sciences; Novartis; OncLive; Roche; Sanofi; SERVIER; Telix Pharmaceuticals; Tocagen
 
Stephan Schoenecker
No Relationships to Disclose
 
Patrick Harter
No Relationships to Disclose
 
Niklas Thon
No Relationships to Disclose
 
Louisa Von Baumgarten
No Relationships to Disclose
 
Nathalie Albert
Honoraria - Advanced Accelerator Applications; Advanced Biochemical Compounds; CarThera; ITM Oncologics; MedSIR; Novartis; OncLive; SERVIER; Telix Pharmaceuticals
Consulting or Advisory Role - Advanced Accelerator Applications; Advanced Biochemical Compounds; CarThera; ITM Oncologics; MedSIR; Novartis; OncLive; SERVIER; Telix Pharmaceuticals
Research Funding - Novocure (Inst); SERVIER (Inst); Telix Pharmaceuticals (Inst)